Adenosine 5′-monophosphate-activated protein kinase-mammalian target of rapamycin cross talk regulates brown adipocyte differentiation

Endocrinology

Volumn 151, Issue 3, 2010, Pages 980-992

  Vila Bedmar, Rocio ^a   Lorenzo, Margarita ^a   Fernández Veledo, Sonia ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOIMIDAZOLE 4 CARBOXAMIDE RIBONUCLEOSIDE; ADENYLATE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RIBONUCLEOSIDE; S6 KINASE; TUBERIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; WNT PROTEIN; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; STK11 PROTEIN, RAT;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; FETUS; IMMUNOHISTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; CELL STRAIN 3T3; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION PROFILING; METABOLISM; SIGNAL TRANSDUCTION; WISTAR RAT;

3T3-L1 CELLS; ADIPOCYTES, BROWN; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION PROFILING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ION CHANNELS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, WISTAR; RECEPTOR CROSS-TALK; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA;

EID: 77149154335     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0810     Document Type: Article

References (56)

1. Lowell BB, Spiegelman BM 2000 Towards a molecular understanding of adaptive thermogenesis. Nature 404:652-660
2. Cannon B, Nedergaard J 2004 Brown adipose tissue: function and physiological significance. Physiol Rev 84:277-359
3. Nedergaard J, Golozoubova V, Matthias A, Asadi A, Jacobsson A, Cannon B 2001 UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim Biophys Acta 1504:82-106
4. Rousset S, ves-Guerra MC, Mozo J, Miroux B, Cassard-Doulcier AM, Bouillaud F, Ricquier D 2004 The biology of mitochondrial uncoupling proteins. Diabetes 53(Suppl 1):S130-S135
5. García-Jimenez C, Hernández A, Obregón MJ, Santisteban P 1993 Malic enzyme gene expression in differentiating brown adipocytes: regulation by insulin and triiodothyronine. Endocrinology 132:1537-1543
6. Cousin B, Cinti S, Morroni M, Raimbault S, Ricquier D, Penicaud L, Casteilla L 1992 Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J Cell Sci 103(Pt 4):931-942
7. Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP 1998 Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest 102:412-420
8. Nedergaard J, Bengtsson T, Cannon B 2007 Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293:E444-E452
9. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR 2009 Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360:1509-1517
10. Zingaretti MC, Crosta F, Vitali A, Guerrieri M, Frontini A, Cannon B, Nedergaard J, Cinti S 2009 The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J 23:3113-3120
11. Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS 1993 Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740-742
12. Ghorbani M, Claus TH, Himms-Hagen J 1997 Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a β3-adrenoceptor agonist. Biochem Pharmacol 54:121-131
13. Kopecky J, Clarke G, Enerbäck S, Spiegelman B, Kozak LP 1995 Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J Clin Invest 96:2914-2923
14. Houstěk J, Vízek K, Pavelka S, Kopecký J, Krejcová E, Hermanská J, Cermáková M 1993 Type II iodothyronine 5′ -deiodinase and uncoupling protein in brown adipose tissue of human newborns. J Clin Endocrinol Metab 77:382-387
15. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM 2000 Transcriptional regulation of adipogenesis. Genes Dev 14:1293-1307
16. Timmons JA, Wennmalm K, Larsson O, Walden TB, Lassmann T, Petrovic N, Hamilton DL, Gimeno RE, Wahlestedt C, Baar K, Nedergaard J, Cannon B 2007 Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci USA 104:4401-4406
17. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scimè A, Devarakonda S, Conroe HM, Erdjument-Bromage H, Tempst P, Rudnicki MA, Beier DR, Spiegelman BM 2008 PRDM16 controls a brown fat/skeletal muscle switch. Nature 454:961-967
18. Sakaue H, Ogawa W, Matsumoto M, Kuroda S, Takata M, Sugimoto T, Spiegelman BM, Kasuga M 1998 Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase. J Biol Chem 273:28945-28952
19. Cao W, Daniel KW, Robidoux J, Puigserver P, Medvedev AV, Bai X, Floering LM, Spiegelman BM, Collins S 2004 p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene. Mol Cell Biol 24:3057-3067
20. Bost F, Aouadi M, Caron L, Binetruy B 2005 The role of MAPKs in adipocyte differentiation and obesity. Biochimie (Paris) 87:51-56
21. Dagon Y, Avraham Y, Berry EM 2006 AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2α in adipocytes. Biochem Biophys Res Commun 340:43-47
22. Habinowski SA, Witters LA 2001 The effects of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 286:852-856
23. Shaw RJ, Cantley LC 2006 Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441:424-430
24. Cai SL, Tee AR, Short JD, Bergeron JM, Kim J, Shen J, Guo R, Johnson CL, Kiguchi K, Walker CL 2006 Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol 173:279-289
25. Inoki K, Zhu T, Guan KL 2003 TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577-590
26. Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, Wang CY, He X, MacDougald OA, You M, Williams BO, Guan KL 2006 TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126:955-968
27. Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, Harrison SD, MacDougald OA 2002 Regulation of Wnt signaling during adipogenesis. J Biol Chem 277:30998-31004
28. Fernández-Veledo S, Nieto-Vazquez I, Rondinone CM, Lorenzo M 2006 Liver X receptor agonists ameliorate TNFα-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression. Diabetologia 49:3038-3048
29. Nieto-Vazquez I, Fernández-Veledo S, de Alvaro C, Rondinone CM, Valverde AM, Lorenzo M 2007 Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-α-induced insulin resistance. Diabetes 56:404-413
30. Kang S, Bajnok L, Longo KA, Petersen RK, Hansen JB, Kristiansen K, MacDougald OA 2005 Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1α. Mol Cell Biol 25:1272-1282
31. de Alvaro C, Teruel T, Hernandez R, Lorenzo M 2004 Tumor necrosis factor α produces insulin resistance in skeletal muscle by activation of inhibitor κB kinase in a p38 MAPK-dependent manner. J Biol Chem 279:17070-17078
32. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE 2001 Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174
33. Aymerich I, Foufelle F, Ferré P, Casado FJ, Pastor-Anglada M 2006 Extracellular adenosine activates AMP-dependent protein kinase (AMPK). J Cell Sci 119:1612-1621
34. Gagnon A, Lau S, Sorisky A 2001 Rapamycin-sensitive phase of 3T3-L1 preadipocyte differentiation after clonal expansion. J Cell Physiol 189:14-22
35. + exchanger 1 in isolated rat ventricular cardiomyocytes. Endocrinology 149:1490-1498
36. Gaidhu MP, Fediuc S, Anthony NM, So M, Mirpourian M, Perry RL, Ceddia RB 2009 Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL. J Lipid Res 50:704-715
37. Bost F, Aouadi M, Caron L, Even P, Belmonte N, Prot M, Dani C, Hofman P, Pagès G, Pouysségur J, Le Marchand-Brustel Y, Binétruy B 2005 The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54:402-411
38. Porras A, Alvarez AM, Valladares A, Benito M 1998 p42/p44 mitogen-activated protein kinases activation is required for the insulin-like growth factor-I/insulin induced proliferation, but inhibits differentiation, in rat fetal brown adipocytes. Mol Endocrinol 12:825-834
39. Qiu Z, Wei Y, Chen N, Jiang M, Wu J, Liao K 2001 DNA synthesis and mitotic clonal expansion is not a required step for 3T3-L1 preadipocyte differentiation into adipocytes. J Biol Chem 276:11988-11995
40. Bell A, Grunder L, Sorisky A 2000 Rapamycin inhibits human adipocyte differentiation in primary culture. Obes Res 8:249-254
41. Cho HJ, Park J, Lee HW, Lee YS, Kim JB 2004 Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem Biophys Res Commun 321:942-948
42. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP 2005 Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121:179-193
43. Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC, Papa A, Nardella C, Cantley LC, Baselga J, Pandolfi PP 2008 Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118:3065-3074
44. Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J, Park OJ 2005 Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338:694-699
45. Gao Y, Zhou Y, Xu A, Wu D 2008 Effects of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cells. Biol Pharm Bull 31:1716-1722
46. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS 2002 AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 277:23977-23980
47. Kimura N, Tokunaga C, Dalal S, Richardson C, Yoshino K, Hara K, Kemp BE, Witters LA, Mimura O, Yonezawa K 2003 A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 8:65-79
48. Inoki K, Li Y, Zhu T,Wu J, Guan KL 2002 TSC2 is phosphorylated and inhibited by Akt and suppressesmTORsignalling. Nat Cell Biol 4:648-657
49. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC 2002 Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 10:151-162
50. Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA, Cantley LC 2004 The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6:91-99
51. Fiedler M, Zierath JR, Selén G, Wallberg-Henriksson H, Liang Y, Sakariassen KS 2001 5-Aminoimidazole-4-carboxy-amide-1-β-D- ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice. Diabetologia 44:2180-2186
52. Giri S, Rattan R, Haq E, Khan M, Yasmin R, Won JS, Key L, Singh AK, Singh I 2006 AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr Metab (Lond) 3:31
53. Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M, Holloszy JO 2000 Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88:2219-2226
54. Luiken JJ, Coort SL, Willems J, Coumans WA, Bonen A, van der Vusse GJ, Glatz JF 2003 Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52:1627-1634
55. Loncar D, Afzelius BA, Cannon B 1988 Epididymal white adipose tissue after cold stress in rats. I. Nonmitochondrial changes. J Ultrastruct Mol Struct Res 101:109-122
56. Collins S, Daniel KW, Petro AE, Surwit RS 1997 Strain-specific response to β3-adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology 138:405-413